Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Boehringer Ingelheim: History, Research & Companies

C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one.

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Boehringer Ingelheim topic overview

The analysis highlights History, Research and Companies as prominent areas in the source structure around Boehringer Ingelheim.

Related topics
154
Source areas
7
Connected nodes
161
Extracted relationships
144
Concept neighborhoods
24
Bridge connections
161

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Products · 64 topics
History · 56 topics
Business overview · 9 topics
Overview · 9 topics
Collaborative research and partnership with Google Quantum AI · 7 topics
Ownership and leadership · 5 topics
Operational sites · 4 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

Founded
1885; 141 years ago (1885) in Ingelheim am Rhein, Germany
Industry
Pharmaceuticals
Owner
Boehringer, Liebrecht and von Baumbach families
Headquarters
Ingelheim, Germany
Area served
Worldwide
Founder
Albert Boehringer

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

History

Business overview

Operational sites

Collaborative research and partnership with Google Quantum AI

Products

Ownership and leadership

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Boehringer Ingelheim connects Entity context

The extracted context around Boehringer Ingelheim shows recurring relationship patterns in the source. For example, Boehringer Ingelheim → Aggrenox, Atrovent, Boehringer Ingelheim Pharmaceuticals, Chief Judge David, Combivent, Drug Administration, Herndon, Illinois, In August, In October, Inc, May, Micardis, On, Pradaxa, Southern District, The, US Food Another extracted example is Boehringer Ingelheim → AMG, Amgen, As, BI, Boehringer, Boehringer Ingelheims Phase, Ceva Santé Animale, Eli Lilly's Elanco Animal, Health, In June, In October, In September, Merial, Sanofi, T-cell, The, US. Use these groups to spot repeated connection types before inspecting the individual relationships.

Boehringer Ingelheim

Top relations

related to Litigation · 18
Boehringer Ingelheim → Aggrenox, Atrovent, Boehringer Ingelheim Pharmaceuticals, Chief Judge David, Combivent, Drug Administration, Herndon, Illinois, In August, In October, Inc, May, Micardis, On, Pradaxa, Southern District, The, US Food
related to 2016 – Sanofi asset swap · 17
Boehringer Ingelheim → AMG, Amgen, As, BI, Boehringer, Boehringer Ingelheims Phase, Ceva Santé Animale, Eli Lilly's Elanco Animal, Health, In June, In October, In September, Merial, Sanofi, T-cell, The, US
related to 2018–onwards · 15
Boehringer Ingelheim → Amal Therapeutics SA, Boehringer, Boehringer Ingelheim Pharmaceuticals, ICD Therapeutics, In, In April, In July, In March, Inc, OSE Immunotherapeutics, OSE's, OSE-172, September, Topas Therapeutics, ViraTherapeutics
related to Operational sites · 14
Boehringer Ingelheim → Asia, Austria, Europe, Frankfurt, Germany, Ingelheim, Mainz, Molecular Pathology, North America, Rhein, The, The Research Institute, Their, Vienna
related to Ownership and leadership · 14
Boehringer Ingelheim → Andreas Barner, As, Baumbach, BI, Board, CEO, CFO Hubertus, Chairman, Christian Boehringer, In, IPO, Johann, Managing Directors, Shareholders’ Committee Dr Heribert
related to Collaborative research and partnership with Google Quantum AI · 13
Boehringer Ingelheim → Application Consortium, EFPIA, European Commission, Google, Google Quantum AI, InnoMed PredTox, Innovative Medicines Initiative, On January, One, Quantum Lab, Quantum Technology, QUTAC, The
related to Closure of Bedford plant · 11
Boehringer Ingelheim → Bedford, Ben Venue, Ben Venue Laboratories, Drug Administration, Food, However, In, October, Ohio, The, US
related to overview · 10
Boehringer Ingelheim → Biberach, Connecticut, Germany, Kobe, Milan, Over, Research, Ridgefield, The, Vienna
related to 2000–2016 · 9
Boehringer Ingelheim → Actimis, Actimis Pharmaceuticals, AP768, Boehringer Ingelheim Shionogi Vetmedica, GmbH, In, In December, In June, STEAG
Key people · 6
Boehringer Ingelheim → Armin Wiesler, Frank Hübler, Harsha Deshmukh, Michael Schmelmer (vice chairman), Paola Casarosa, Shashank Deshpande (chairman of the board)

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

boehringer ingelheim company announced pharmaceuticals research million would animal health business cancer pharmaceutical albert acquire drug therapeutics private founded 1885

Boehringer Ingelheim relationships Subject–Predicate–Object triples

TTTA extracted 144 structured relationships around Boehringer Ingelheim. Examples in this analysis include Boehringer Ingelheim → Area served → Worldwide and Boehringer Ingelheim → Founded → 1885; 141 years ago (1885) in Ingelheim am Rhein, Germany. The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
Boehringer IngelheimArea servedWorldwide1.00infobox
Boehringer IngelheimFounded1885; 141 years ago (1885) in Ingelheim am Rhein, Germany1.00infobox
Boehringer IngelheimFounderAlbert Boehringer1.00infobox
Boehringer IngelheimHeadquartersIngelheim, Germany1.00infobox
Boehringer IngelheimIndustryPharmaceuticals1.00infobox
Boehringer IngelheimKey peopleShashank Deshpande (chairman of the board)1.00infobox
Boehringer IngelheimKey peopleMichael Schmelmer (vice chairman)1.00infobox
Boehringer IngelheimKey peoplePaola Casarosa1.00infobox
Boehringer IngelheimKey peopleFrank Hübler1.00infobox
Boehringer IngelheimKey peopleArmin Wiesler1.00infobox
Boehringer IngelheimKey peopleHarsha Deshmukh1.00infobox
Boehringer IngelheimNumber of employees54,300 (2025)1.00infobox
Boehringer IngelheimOwnerBoehringer, Liebrecht and von Baumbach families1.00infobox
Boehringer IngelheimProductsPharmaceuticals and Animal Health1.00infobox
Boehringer IngelheimRevenue€27.8 billion (2025)1.00infobox
Boehringer IngelheimTypePrivate1.00infobox
Boehringer IngelheimWebsiteboehringer-ingelheim.com1.00infobox
Boehringer Ingelheimis afull member of the European Federation of Pharmaceutical Industries and Associations0.90text
Boehringer Ingelheimis afirst pharmaceutical company worldwide to join forces with Google in quantum computing in a newly established Quantum Lab of Boehringer Ingelheim0.90text

Related concept clusters Concept neighborhoods

The concept neighborhoods around Boehringer Ingelheim bring nearby vocabulary together. In this analysis, examples include Ingelheim, Announced and Company. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • Boehringer Ingelheim
    • Ingelheim
    • Announced
    • Company
    • Animal
    • Health
    • Pharmaceuticals
    • Albert
    • Research
    • Founded
    • Subsidiary
    • Pharmaceutical
    • Employees
  • boehringer ingelheim
    • Ingelheim
    • Announced
    • Founded
    • Subsidiary
    • Pharmaceuticals
    • Company
    • Research
    • Kg
    • Animal
    • Health
    • Inc
    • Pharmaceutical
  • ingelheim am rhein
    • Germany
    • Kg
    • Founded
    • Albert
    • Key
    • Subsidiary
    • Company's
    • Employees
    • Private
    • Pharmaceuticals
    • Billion
    • Research
  • elanco animal health
    • Health
    • Sold
    • Business
    • Pharmaceuticals
    • Billion
    • October
    • Boehringer
    • Ingelheim
    • Company
    • Million
    • Would
    • Key
  • animal health
    • Health
    • Sold
    • Business
    • Pharmaceuticals
    • Billion
    • October
    • Boehringer
    • Ingelheim
    • Company
    • Million
    • Would
    • Key
  • business overview
    • Animal
    • Health
    • Inc
    • Million
    • Subsidiary
    • Would
    • Sold
    • Acquire
    • Announced
    • Pharmaceuticals
    • Company
    • Key
  • actimis pharmaceuticals
    • Inc
    • Million
    • Announced
    • Subsidiary
    • Sold
    • Rhein
    • Private
    • Acquired
    • Cancer
    • Therapeutics
    • Acquire
    • Drug
  • hikma pharmaceuticals
    • Inc
    • Million
    • Announced
    • Subsidiary
    • Sold
    • Rhein
    • Private
    • Acquired
    • Cancer
    • Therapeutics
    • Acquire
    • Drug

Connections between topic areas Semantic bridges

For Boehringer Ingelheim, one of the stronger structural bridges in this analysis connects Boehringer Ingelheim with Products. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3
Boehringer IngelheimProducts · splits 97 ⟂ 65
Boehringer IngelheimHistory · splits 105 ⟂ 57
Boehringer IngelheimOverview · splits 152 ⟂ 10
Boehringer IngelheimBusiness overview · splits 152 ⟂ 10
Boehringer IngelheimCollaborative research and partnership with Google Quantum AI · splits 154 ⟂ 8
Boehringer IngelheimOwnership and leadership · splits 156 ⟂ 6
Boehringer IngelheimOperational sites · splits 157 ⟂ 5

Map overview Semantic statistics

Boehringer Ingelheim

Nodes162
Edges161
Triples144
Avg. degree1.99
Density0.012346
Components1

Source & methodology

TTTA analyzes the structure around Boehringer Ingelheim to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Research & Companies, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Boehringer Ingelheim · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.